SATB1 mediated tumor colonization and β-catenin nuclear localization are associated with colorectal cancer progression

Colorectal cancer (CRC) is a malignancy with high incidence and poor prognosis. It is urgent to identify valuable biomarkers for early diagnosis and potent therapeutic targets. It has been reported that SATB1 is associated with the malignant progression in CRC. To explore the role of SATB1 in CRC progression and the underlying mechanism, we evaluated the expression of SATB1 in the paired CRC tissues with immunohistochemistry. The results showed that the expression of SATB1 in lymph node metastasis was higher than that in primary lesion, and that in distant organ metastasis was higher than that in primary lesion. The retrospective analysis showed that patients with high expression of SATB1 had a significantly worse prognosis than those with negative and moderate expression. In vitro experiments that employing SATB1 over-expressing and depleted CRC cell lines confirmed that SATB1 contributes to cell proliferation and colonization, while inhibiting cell motility. Furthermore, the tissue immunofluorescence assay, Co-IP and Western blot were conducted to reveal that SATB1 induced translocation of β-catenin and formed a protein complex with it in the nuclei. In conclusion, SATB1 mediated tumor colonization and β-catenin nuclear localization are associated with the malignant progression and poor prognosis of CRC.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:25

Enthalten in:

Cancer biology & therapy - 25(2024), 1 vom: 31. März, Seite 2320307

Sprache:

Englisch

Beteiligte Personen:

Sun, Luan [VerfasserIn]
Wang, Feng [VerfasserIn]
Wang, Xufei [VerfasserIn]
Zhang, Feiying [VerfasserIn]
Ma, Sujuan [VerfasserIn]
Lv, Jinghuan [VerfasserIn]

Links:

Volltext

Themen:

β-catenin
Beta Catenin
Colorectal cancer progression
Journal Article
Matrix Attachment Region Binding Proteins
Research Support, Non-U.S. Gov't
SATB1
SATB1 protein, human
Transcription Factors
Tumor colonization

Anmerkungen:

Date Completed 23.02.2024

Date Revised 11.03.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1080/15384047.2024.2320307

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM368756351